Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 1/2 1

Status

Recruiting 5Active not recruiting 3

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Dermatologic 2Other hematologic neoplasm 1Lymphoid 1Gynecologic 1CNS 1

Conditions

Melanoma 2Warts 1Ovarian Neoplasms 1Lymphoma, T-Cell 1Hyperthermia 1Hemorrhage 1Hematologic Neoplasms 1Brain Neoplasms 1

Interventions

Specimen Handling 482pembrolizumab 454Magnetic Resonance Spectroscopy 419Carboplatin 321Cyclophosphamide 314Biopsy 272Cisplatin 264Radiotherapy 241Paclitaxel 226Gemcitabine 224Bevacizumab 212Nivolumab 189fludarabine 183venetoclax 172Drug Therapy 166Dexamethasone 157Blood Specimen Collection 156Oxaliplatin 154Injections 152Capecitabine 152Fluorouracil 144Docetaxel 143Standard of Care 136Radiosurgery 136Rituximab 125Pemetrexed 115durvalumab 113atezolizumab 110Leucovorin 110Radiation 105

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Solutions × 1 year × Clear all
NCT07565350 2026-05-04

Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts

First Hospital of China Medical University

Phase NA Recruiting
80 enrolled

Hyperthermia, Warts

NCT05952804 2026-04-21

IVIG for Infection Prevention After CAR-T-Cell Therapy

Fred Hutchinson Cancer Center

Phase 2 Recruiting
150 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT06229483 2026-03-19

The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies

Nova Scotia Health Authority

Phase 3 Recruiting
102 enrolled
CNS

Brain Neoplasms, Hemorrhage

NCT04752826 2026-02-18

MK-3475-D20

BioInvent International AB

Phase 1/2 Recruiting
176 enrolled
DermatologicGynecologicLymphoid

Melanoma, Ovarian Neoplasms, Lymphoma, T-Cell

NCT07230613 2026-02-11

NEOREM-NEO-1

UNICANCER

Phase 2 Recruiting
50 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡